Patent details
EP2806877 Title: NEUROACTIVE STEROID FORMULATIONS COMPRISING A COMPLEX OF ALLOPREGNANOLONE AND SULFOBUTYL ETHER BETA-CYCLODEXTRIN
Basic Information
- Publication number:
- EP2806877
- PCT Application Number:
- US2013022772
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP137407433
- PCT Publication Number:
- WO2013112605
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- NEUROACTIVE STEROID FORMULATIONS COMPRISING A COMPLEX OF ALLOPREGNANOLONE AND SULFOBUTYL ETHER BETA-CYCLODEXTRIN
- French Title of Invention:
- FORMULATIONS DE STÉROÏDES NEUROACTIFS COMPRENANT UN COMPLEXE D'ALLOPREGNANOLONE ET DE SULFOBUTYL ETHER BETA-CYCLODEXTRINE
- German Title of Invention:
- NEUROAKTIVE STEROID-FORMULIERUNGEN MIT EINEM KOMPLEX AUS ALLOPREGNANOLON UND SULFOBUTYLETHER BETA-CYCLODEXTRIN
- SPC Number:
Dates
- Filing date:
- 23/01/2013
- Grant date:
- 09/10/2019
- EP Publication Date:
- 03/12/2014
- PCT Publication Date:
- 01/08/2013
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/10/2019
- EP B1 Publication Date:
- 09/10/2019
- EP B2 Publication Date:
- 29/01/2025
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 23/01/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 22/01/2025
- Name:
- Sage Therapeutics, Inc.
- Address:
- 55 Cambridge Parkway, Cambridge, MA 02142, United States (US)
History of Owners
- From:
- 02/10/2019
- To:
- 26/12/2024
- Name:
- Sage Therapeutics, Inc.
- Address:
- 215 First Street, Cambridge, MA 02142, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 25/11/2019
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- REDDY, Kiran
- Address:
- United States (US)
Priority
- Priority Number:
- 201261589740 P
- Priority Date:
- 23/01/2012
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/57; A61K 47/69; A61P 25/00; A61P 25/08;
Publication
European Patent Bulletin
1
- Issue number:
- 201941
- Publication date:
- 09/10/2019
- Description:
- Grant (B1)
2
- Issue number:
- 202033
- Publication date:
- 12/08/2020
- Description:
- Opposition procedure started
3
- Issue number:
- 202505
- Publication date:
- 29/01/2025
- Description:
- Patent maintained (B2 publication)
4
- Issue number:
- 201942
- Publication date:
- 16/10/2019
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
5
- Issue number:
- 202505
- Publication date:
- 29/01/2025
- Description:
- Change of owner's name or address
Annual Fees
- Annual Fee Due Date:
- 02/02/2026
- Annual Fee Number:
- 14
- Annual Fee Amount:
- 198 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 14/01/2025
- Last Annual Fee Paid Number:
- 13
- Last Annual Fee Paid Amount:
- 180 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 25/11/2019 | Outgoing Correspondence | 1 |
| 25/11/2019 | Power Of Attorney | 1 |